Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sysmex's haematology analyser:

This article was originally published in Clinica

Executive Summary

The XE-5000 automated haematology analyser developed by Sysmex America has been granted 510(k) approval by the US FDA. It uses Sysmex's fluorescent flow cytometry technology to provide both routine haematology testing and abnormal cell flagging within a single sample run. The XE-5000 can be remotely monitored by Sysmex technicians, who can help correct any issues prior to system or part failures. The device will be on sale in the US, Latin America and in Canada within the month and is aimed at hospital or university laboratories and clinics with renal, oncology and acute care patient populations. Sysmex America, of Mundelein, Illinois, is the US headquarters of Kobe, Japan-based Sysmex.

You may also be interested in...

Latest UK COVID-19 Specification: For Rapidly Manufactured CPAP Systems

Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.

Podcast: Biopharma's Moment To Deliver On Coronavirus And The People's Hope

Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.

Hengrui Quickly Fills Celgene Void Amid Nationalism Surge In China

China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts